We are live on ! Find out more
TCP

Tyndall Capital Partners Portfolio holdings

AUM $452K
1-Year Est. Return 26.52%
This Fund
S&P 500
This Quarter Est. Return
-15.46%
1 Year Est. Return
+26.52%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.84M
AUM Growth
+$367K
Cap. Flow
+$1.4M
Cap. Flow %
36.43%
Top 10 Hldgs %
100%
Holding
3
New
Increased
1
Reduced
Closed

Top Buys

Rank Stock Value
1
TRAW icon
Traws Pharma
TRAW
+$1.4M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Financials 51.37%
2 Healthcare 45.59%
3 Miscellaneous 3.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MMAC
1
DELISTED
MMA Capital Holdings, Inc. Common Stock
MMAC
$1.97M 51.37%
72,552
TRAW icon
2
Traws Pharma
TRAW
$9.17M
$1.75M 45.59%
373
+196
+111% +$1.4M
ONTXW
3
DELISTED
Onconova Therapeutics, Inc. Warrants
ONTXW
$117K 3.05%
390,624

Similar funds

Tyndall Capital Partners's Q1 2018 Portfolio in Review

As of Q1 2018, Tyndall Capital Partners held 3 positions worth $3.84M, up 11% from $3.47M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Tyndall Capital Partners deployed $1.4M of net new capital in Q1 2018, adding to 1 existing holding.

By sector, the portfolio is most concentrated in Financials at 51% of assets, up from 51% a quarter earlier, followed by Healthcare and Miscellaneous.

  • Tyndall Capital Partners added most to Traws Pharma in Q1 2018, an estimated $1.4M increase.
  • Tyndall Capital Partners's ten largest holdings make up 100% of its $3.84M portfolio in Q1 2018.
  • Tyndall Capital Partners opened 0 new positions and closed 0 in Q1 2018.
  • Tyndall Capital Partners's portfolio value rose 11% quarter-over-quarter to $3.84M.

Based on Tyndall Capital Partners's 13F filing for Q1 2018, filed 15 May 2018.